A Study to Investigate the Effects of Moderate or Severe Renal Impairment (RI) on Velzatinib

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study evaluates the effect of moderate and severe renal impairment on the pharmacokinetics (PK) of velzatinib compared with normal renal function.
Epistemonikos ID: 09683da66a4b1aab52dc35d1dfbddcdacaeb2b18
First added on: Oct 10, 2026